IFNG and ovarian cancer: Day-4 lysate pulsed DCs were as potent as Day-7 DCs in stimulating autologous T cells in both healthy donors as well as in ovarian cancer patients; these T cells recognized live ovarian tumor cell lines and ovarian tumor-associated antigens, and produced IFN-γ as a result.